2024
|
Invention
|
Combination comprising a glucocorticoid and edo-s101.
The present invention is directed to a com... |
|
Invention
|
Combinations for treating cancer.
The invention relates to combinations, pharmaceutical composit... |
2023
|
Invention
|
Hodgkin lymphoma therapy.
There is provided a compound of formula I or a pharmacologically accep... |
2022
|
Invention
|
Combination comprising a glucocorticoid and edo-s101. The present invention is directed to a comb... |
|
Invention
|
Compounds for treating brain cancer. There is provided a compound of formula I or a pharmacologic... |
|
Invention
|
Hodgkin lymphoma therapy. There is provided a compound of formula I or a pharmacologically accept... |
2021
|
Invention
|
Pharmaceutical combinations for treating cancer. The present invention is directed to a combinati... |
2019
|
Invention
|
Pharmaceutical combinations for treating cancer.
The present invention is directed to a combinat... |
2016
|
Invention
|
Hodgkin lymphoma therapy.
There is provided a method of treating Hodgkin lymphoma in a patient i... |
|
Invention
|
Methods of treating opiate dependency and preventing non-oral opiate abuse among opiate addicts. ... |
2015
|
Invention
|
Pharmaceutical combination comprising a class iii receptor tyrosine kinase inhibitor and the alky... |
2013
|
Invention
|
Hydroxamic acid derivatives. The present invention is directed to a method of alleviating, reliev... |
|
Invention
|
Therapeutic agents. The present invention relates to a class of hydroxamic acid compounds of Form... |
|
Invention
|
Novel therapeutic agents. The present invention relates to a class of hydroxamic acid compounds o... |
2012
|
Invention
|
Nitrogen mustard derivatives. 2 are defined herein. Also disclosed is a method for treating a neo... |
|
Invention
|
Nitrogen mustard derivatives. The disclosure includes compounds of Formula (1): wherein X1, X2, Q... |
|
Invention
|
Pharmaceutical compositions. The present invention is directed to pharmaceutical compositions com... |
2011
|
Invention
|
Hydroxamic acid derivatives. The disclosure includes hydroxamic compounds of Formula I: (I) where... |
2010
|
Invention
|
Low-profile intraluminal light delivery system and methods of using the same.
A light delivery s... |
|
Invention
|
Immune system stimulation by light therapy induced apoptotic cell death in abnormal tissue.
The ... |
2007
|
Invention
|
Use of a combination of morphine and at least one opiate antagonist to treat opiate dependency an... |
2006
|
Invention
|
Implantable device for therapeutic treatment within a body lumen.
A treatment system to provide ... |
|
G/S
|
pharmaceutical preparations for the prevention and treatment of insomnia and other sleep-related ... |
2001
|
Invention
|
Contactless energy transfer apparatus. A flux generator base unit electromagnetically coupled wit... |
1997
|
Invention
|
Enhancement of light activation effect by immune augmentation. The efficacy of a plurality of PDT... |
|
Invention
|
Method and pdt probe for minimizing ct and mri image artifacts. An implantable probe having a non... |
|
Invention
|
Flexible and adjustable grid for medical therapy. Flexible probes are arranged to achieve a desir... |
|
Invention
|
Compact flexible circuit configuration. A flexible probe constructed using a flexible circuit hav... |
|
Invention
|
Use of a shape memory alloy to modify the disposition of a device within an implantable medical p... |
1996
|
Invention
|
Electromagnetic coil configurations for power transmission through tissue. Several embodiments of... |
|
Invention
|
Transcutaneous electromagnetic energy transfer. A method and apparatus for enhancing transcutaneo... |
|
Invention
|
Method and device for applying hyperthermia to enhance drug perfusion and efficacy of subsequent ... |
|
Invention
|
Implanting and fixing a flexible probe for administering a medical therapy at a treatment site wi... |
|
Invention
|
Flexible microcircuits for internal light therapy. A plurality of embodiments for a flexible prob... |
1993
|
Invention
|
Method and apparatus for providing light-activated therapy. Light developed by an implantable pro... |